Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of an Investigational Medication for Severe Primary Hyperparathyroidism or Parathyroid Cancer
This study has been completed.
Study NCT00037518   Information provided by Amgen
First Received: May 17, 2002   Last Updated: October 15, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperparathyroidism
Parathyroid Neoplasms
Additional conditions recognized in this trial
Hyperparathyroidism, Primary
Neoplasms
More general conditions related to this trial
Endocrine Gland Neoplasms
Endocrine System Diseases
Head and Neck Neoplasms
Neoplasms by Site
Parathyroid Diseases
Interventions listed in this trial
AMG 073
Sponsors listed in this trial
Amgen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services